Opaleye Management as of March 31, 2017
Portfolio Holdings for Opaleye Management
Opaleye Management holds 44 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 17.5 | $35M | 880k | 39.99 | |
| Axogen (AXGN) | 10.2 | $21M | 2.0M | 10.45 | |
| Fibrogen (FGEN) | 4.0 | $8.1M | 330k | 24.65 | |
| Noveliontherapeuti.. | 3.9 | $7.8M | 730k | 10.74 | |
| Chimerix (CMRX) | 3.9 | $7.8M | 1.2M | 6.38 | |
| Agios Pharmaceuticals (AGIO) | 3.8 | $7.6M | 130k | 58.40 | |
| Cara Therapeutics (CARA) | 3.5 | $7.1M | 385k | 18.39 | |
| Theravance Biopharma (TBPH) | 3.3 | $6.6M | 180k | 36.82 | |
| Immunomedics | 3.1 | $6.2M | 960k | 6.47 | |
| Momenta Pharmaceuticals | 2.9 | $5.9M | 440k | 13.35 | |
| Cytomx Therapeutics (CTMX) | 2.9 | $5.9M | 340k | 17.27 | |
| Codexis (CDXS) | 2.8 | $5.6M | 1.2M | 4.80 | |
| Strongbridge Bioph shs usd | 2.8 | $5.6M | 1.2M | 4.75 | |
| Loxo Oncology | 2.7 | $5.5M | 130k | 42.08 | |
| Ocular Therapeutix (OCUL) | 2.5 | $5.1M | 550k | 9.28 | |
| Adamas Pharmaceuticals | 2.5 | $5.1M | 290k | 17.50 | |
| Prothena (PRTA) | 2.4 | $4.9M | 87k | 55.79 | |
| Eagle Pharmaceuticals (EGRX) | 2.1 | $4.1M | 50k | 82.94 | |
| Imprimis Pharmaceuticals | 1.8 | $3.6M | 861k | 4.17 | |
| Sage Therapeutics (SAGE) | 1.6 | $3.2M | 45k | 71.07 | |
| Neuroderm Ltd F | 1.6 | $3.2M | 120k | 26.55 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $3.1M | 100k | 30.80 | |
| Sangamo Biosciences (SGMO) | 1.5 | $3.0M | 581k | 5.20 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.3 | $2.6M | 1.9M | 1.36 | |
| Edge Therapeutics | 1.3 | $2.6M | 280k | 9.11 | |
| Foamix Pharmaceuticals | 1.2 | $2.5M | 500k | 4.95 | |
| Zosano Pharma | 1.2 | $2.4M | 1.3M | 1.90 | |
| Sunesis Pharmaceuticals Inc Ne | 1.1 | $2.3M | 550k | 4.10 | |
| Wave Life Sciences (WVE) | 1.1 | $2.2M | 78k | 27.50 | |
| Aevi Genomic | 1.0 | $2.0M | 1.1M | 1.86 | |
| Portola Pharmaceuticals | 1.0 | $2.0M | 50k | 39.18 | |
| Lion Biotechnologies | 0.8 | $1.7M | 230k | 7.45 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $1.4M | 360k | 4.00 | |
| Aquinox Pharmaceuticals | 0.7 | $1.4M | 85k | 16.68 | |
| Abeona Therapeutics | 0.7 | $1.4M | 275k | 5.00 | |
| Tonix Pharmaceuticls | 0.6 | $1.1M | 235k | 4.67 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.5 | $956k | 123k | 7.80 | |
| Albireo Pharma | 0.4 | $876k | 37k | 24.00 | |
| Karyopharm Therapeutics (KPTI) | 0.4 | $770k | 60k | 12.83 | |
| Corium Intl | 0.3 | $677k | 162k | 4.18 | |
| ArQule | 0.3 | $594k | 560k | 1.06 | |
| Syros Pharmaceuticals | 0.2 | $400k | 25k | 15.91 | |
| Xoma Corp Del (XOMA) | 0.1 | $287k | 40k | 7.10 | |
| Biolinerx Ltd-spons | 0.1 | $240k | 250k | 0.96 |
